<p>The following table shows total approximate spend for the Additional Roles Reimbursement Scheme (ARRS) as well as for the recruitment of clinical pharmacists:</p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Pharmacist spend (£ million)</p></td><td><p>ARRS (£ million)</p></td></tr><tr><td><p>2019/20</p></td><td><p>34</p></td><td><p>53</p></td></tr><tr><td><p>2020/21</p></td><td><p>137</p></td><td><p>267</p></td></tr><tr><td><p>2021/22</p></td><td><p>216</p></td><td><p>519</p></td></tr><tr><td><p>2022/23</p></td><td><p>TBC</p></td><td><p>TBC</p></td></tr><tr><td><p>Total amount</p></td><td><p>387</p></td><td><p>839</p></td></tr></tbody></table><p>Notes:</p><ol><li>Spend on clinical pharmacists is based on data reported by primary care networks and integrated care boards and does not include advanced practitioner pharmacists or pharmacy technicians.</li><li>Data for 2022/23 is currently not available as it is unvalidated.</li></ol><p>NHS England has committed to review the ARRS during 2023/24. This work will cover the performance of the scheme to date and inform the Government’s approach to any future support for additional clinical roles in general practice.</p>